Donna Skee

Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin

Damayanthi Devineni, Linda Morrow, Marcus Hompesch et al. · Diabetes Obesity and Metabolism · 2012 · 221 citations

Medicine, Pharmacokinetics, Pharmacology +17

Absorption, Metabolism, and Excretion of Oral 14C Radiolabeled Ibrutinib: An Open-Label, Phase I, Single-Dose Study in Healthy Men

Ellen Scheers, Laurent Leclercq, Jan de Jong et al. · Drug Metabolism and Disposition · 2014 · 138 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Effect of <scp>CYP</scp>3A perpetrators on ibrutinib exposure in healthy participants

Jan de Jong, Donna Skee, Joe Murphy et al. · Pharmacology Research & Perspectives · 2015 · 99 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Pharmacokinetics of a contraceptive patch (Evra^™/Ortho Evra^™) containing norelgestromin and ethinyloestradiol at four application sites

Larry S. Abrams, Donna Skee, Jaya Natarajan et al. · British Journal of Clinical Pharmacology · 2002 · 92 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

Philippe Moreau, Ievgenii Karamanesht, Maryna Kyselyova et al. · Clinical Pharmacokinetics · 2012 · 85 citations

Medicine, Pharmacokinetics, Pharmacology +14